Our team has been involved in more than 100 life sciences M&A
deals for consideration in excess of $300 billion
Mergers & Acquisitions
Torreya Partners is one of the most active players
in the life sciences in Mergers & Acquisitions advisory.
We are involved in a variety of situations including:
Corporate sales (sellside advisor)
Acquisitions (buyside advisor)
Defense strategies and shareholder rights plans
The most common M&A situation for Torreya Partners is
to act as a sellside advisor for an emerging company in the life
sciences which has or is likely to draw interest from a larger company —
interested in either a partnership or an acquisition. Our process and approach
is very similar to that followed in licensing processes.
We carefully execute
the preparation of non-confidential and confidential materials, engagement of
potential acquirers, immersion in the diligence process, drawing out of offers,
negotiation of offers and guidance to Boards of Directors in considering and
Our practice is founded upon experience and deep domain knowledge in the
life sciences. Our knowledge of the underlying science, regulatory factors and
people in the life sciences sector differentiates us. Our history of successfully
carrying out numerous M&A transactions has built up a base of intellectual
capital that repeatedly proves valuable in transactions that are typically of
high importance to our clients.
In total, we bring over 200 years of collective experience in the life
sciences sector in M&A and financing deals and have collectively carried
out more than 100 M&A transactions for consideration in excess of $300 billion.
Mergers & Acquisitions Team
Partner and Co-Head of North American Transactions